BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12587836)

  • 21. A short course of oral prednisone followed by intranasal budesonide is an effective treatment of severe nasal polyps.
    Benítez P; Alobid I; de Haro J; Berenguer J; Bernal-Sprekelsen M; Pujols L; Picado C; Mullol J
    Laryngoscope; 2006 May; 116(5):770-5. PubMed ID: 16652085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic value of the prick test and tissue RAST in allergic nasal polyposis].
    Philipp A; Koch T; Becker S; Soudah B
    HNO; 1991 May; 39(5):185-7. PubMed ID: 1874636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intranasal budesonide irrigations on intraocular pressure.
    Seiberling KA; Chang DF; Nyirady J; Park F; Church CA
    Int Forum Allergy Rhinol; 2013 Sep; 3(9):704-7. PubMed ID: 23704078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of chosen cytokines in etiology of nasal polyps].
    Pietruszewska W; Olejniczak I; Gryczyński M
    Pol Merkur Lekarski; 2005 Sep; 19(111):273-5. PubMed ID: 16358840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term follow-up of pulmonary function in patients with nasal polyposis.
    Lamblin C; Brichet A; Perez T; Darras J; Tonnel AB; Wallaert B
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):406-13. PubMed ID: 10673178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymptomatic IgE mediated food hypersensitivity in patients with nasal polyps.
    Doğru H; Tüz M; Uygur K; Akkaya A; Yasan H
    Asian Pac J Allergy Immunol; 2003 Jun; 21(2):79-82. PubMed ID: 14629124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nasal polyposis: prevalence of positive food and inhalant skin tests.
    Collins MM; Loughran S; Davidson P; Wilson JA
    Otolaryngol Head Neck Surg; 2006 Nov; 135(5):680-3. PubMed ID: 17071293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Etiology of nasal polyps: an update].
    Pietruszewska W; Olejniczak I; Józefowicz-Korczyaska M; Gryczyński M
    Otolaryngol Pol; 2006; 60(4):551-7. PubMed ID: 17152808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of allergy in the severity of nasal polyposis.
    Erbek SS; Erbek S; Topal O; Cakmak O
    Am J Rhinol; 2007; 21(6):686-90. PubMed ID: 17883886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the efficacy of nasal drop and nasal spray applications of fluticasone propionate in nasal polyps.
    Demirel T; Orhan KS; Keleş N; Değer K
    Kulak Burun Bogaz Ihtis Derg; 2008; 18(1):1-6. PubMed ID: 18443395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of topical budesonide treatment on glucocorticoid receptor mRNA down-regulation and cytokine patterns in nasal polyps.
    Henriksson G; Norlander T; Forsgren J; Stierna P
    Am J Rhinol; 2001; 15(1):1-8. PubMed ID: 11258648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of IgE-mediated hypersensitivity on nasal mucociliary clearance.
    Kirtsreesakul V; Somjareonwattana P; Ruttanaphol S
    Arch Otolaryngol Head Neck Surg; 2010 Aug; 136(8):801-6. PubMed ID: 20713757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Fluticasone Furoate on Clinical and Immunological Outcomes (IL-17) for Patients With Nasal Polyposis Naive to Steroid Treatment.
    Venkatesan N; Lavigne P; Lavigne F; Hamid Q
    Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):213-8. PubMed ID: 26405064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of systemic steroid treatment in sinonasal polyposis.
    Berkiten G; Salturk Z; Topaloğlu I
    J Craniofac Surg; 2013 May; 24(3):e305-8. PubMed ID: 23715001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical aspects and distribution of immunologically active cells in the nasal mucosa of patients with nasal polyps after endoscopic sinus surgery and treatment with topical corticosteroids.
    Stoop AE; van der Heijden HA; Biewenga J; van der Baan S
    Eur Arch Otorhinolaryngol; 1992; 249(6):313-7. PubMed ID: 1358129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allergenic profile of nasal polyposis.
    Muñoz del Castillo F; Jurado-Ramos A; Fernández-Conde BL; Soler R; Barasona MJ; Cantillo E; Moreno C; Guerra F
    J Investig Allergol Clin Immunol; 2009; 19(2):110-6. PubMed ID: 19476014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral steroids and doxycycline: two different approaches to treat nasal polyps.
    Van Zele T; Gevaert P; Holtappels G; Beule A; Wormald PJ; Mayr S; Hens G; Hellings P; Ebbens FA; Fokkens W; Van Cauwenberge P; Bachert C
    J Allergy Clin Immunol; 2010 May; 125(5):1069-1076.e4. PubMed ID: 20451040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of systemic, topical, and intralesional steroid treatments on apoptosis level of nasal polyps.
    Kapucu B; Cekin E; Erkul BE; Cincik H; Gungor A; Berber U
    Otolaryngol Head Neck Surg; 2012 Sep; 147(3):563-7. PubMed ID: 22555894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of intercellular adhesion molecule-1 on the vascular endothelium in nasal polyps before, during and after topical glucocorticoid treatment.
    Tingsgaard PK; Larsen PL; Bock T; Lange Vejlsgaard G; Tos M
    Acta Otolaryngol; 1998 Jun; 118(3):404-8. PubMed ID: 9655217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Budesonide turbuhaler delivered once daily improves health-related quality of life in adult patients with non-steroid-dependent asthma.
    Banov C; Howland WC; Lumry WR; Parasuraman B; Uryniak T; Liljas B
    Allergy Asthma Proc; 2003; 24(2):129-36. PubMed ID: 12776447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.